A new treatment option for patients with haematological cancers
The Jules Bordet Institute is now one of 7 Belgian centres to propose treatment with CAR-T cells for haematological cancer patients.
Bordet News 136 (July 2023)
Subsides 2022 - Radiothérapie - Flash Thérapie - Cancer du sein - Analyse spatiale de l'hétérogénité moléculaire des tumeurs
Yasmina Coomans
Department :
Information security
Importance of multidisciplinary care for head and neck cancers
“Head and neck” cancers cover all the tumours that develop in the upper aero-digestive tract or ENT
Lung cancer: standardize practices for the benefit of the patient
A new consensus definition to define the resectability of stage III non-small cell lung cancers (Dr Brandao, Bordet Institute)
Pink October : Artificial intelligence for breast cancer screening
This year as every year, October is the month to boost awareness of breast cancer.
Pink October - A personalised support programe for patients after breast cancer
The RESTART programme offers patients with breast cancer in remission a multidisciplinary and personalised follow-up
Did you take your ID card?
One trip to the hospital = one presentation of electronic ID (eID, ISI+ card or KidsID if the patient is a child)
Movember 2023
Movember, a campaign to boost awareness of male cancers
Changes to the procedure for sending paper medical documents
From November 2nd, the H.U.B will stop systematically sending medical documents in paper format.
Join us in the fight against antimicrobial resistance!
Global Antimicrobial Resistance Awareness Week (18-24 November 2023)
Non à la violence à l’Hôpital, oui au respect
Unis contre la maladie, le respect est notre prescription pour de meilleurs soins.
Christine Collen
Department :
Radiotherapy
02/541.38.00
Mathilde Bare
Department :
Radiotherapy
02/541.38.00
Martin Manderlier
Department :
Radiotherapy
02/541.38.00
Nicolas Jullian
Department :
Radiotherapy
02/541.38.00
Daphné Van Kampen
Department :
Radiotherapy
02/541.38.00
Nuria Nuria Santamaria Guinea
Department :
Medical Imagery
+32 (0)2 541 73 74 (rdv)
Cancer du sein et prédisposition héréditaire liée au BRCA – Rencontres entre experts et patients
le 5 février 2024 – 18h à 21h à l'Institut Jules Bordet – Auditoire Tagnon
Fabio Silvio Taccone
Department :
Intensive care unit
02/555.44.45